SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-140336
Filing Date
2021-04-29
Accepted
2021-04-29 16:01:52
Documents
6
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d170160ddef14a.htm DEF 14A 388483
2 GRAPHIC g170160g02e64.jpg GRAPHIC 20291
3 GRAPHIC g170160g02w64.jpg GRAPHIC 22068
4 GRAPHIC g170160g15s86.jpg GRAPHIC 43622
5 GRAPHIC g170160g43w64.jpg GRAPHIC 155671
6 GRAPHIC g170160g44e64.jpg GRAPHIC 181709
  Complete submission text file 0001193125-21-140336.txt   973260
Mailing Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010
Business Address 866 MALCOLM ROAD, SUITE 100 BURLINGAME CA 94010 650-466-7125
ALX ONCOLOGY HOLDINGS INC (Filer) CIK: 0001810182 (see all company filings)

IRS No.: 850642577 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39386 | Film No.: 21870330
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences